Jared Freedberg's Net Worth
$1.24 Million
Who is Jared Freedberg?
Jared Freedberg has an estimated net worth of $1.24 Million. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, and INTERCEPT PHARMACEUTICALS, INC..
SEC CIK
Jared Freedberg's CIK is 0001754157
Past Insider Trading and Trends
2019 was Jared Freedberg's most active year for acquiring shares with 3 total transactions. Jared Freedberg's most active month to acquire stocks was the month of December. 2023 was Jared Freedberg's most active year for disposing of shares, totalling 9 transactions. Jared Freedberg's most active month to dispose stocks was the month of October. 2018 saw Jared Freedberg paying a total of $0.00 for 119,685 shares, this is the most they've acquired in one year. In 2023 Jared Freedberg cashed out on 166,674 shares for a total of $1,125,513.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNOMEDICS INC No price found
Gen. Counsel & Corp. Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTERCEPT PHARMACEUTICALS, INC. (ICPT) No price found
General CounselJared Freedberg used to own units in Common Stock but no longer holds any shares there. From 2021 to 2023 Jared Freedberg acquired a total of 66,777 shares in INTERCEPT PHARMACEUTICALS, INC., Jared also disposed a total of 66,777 shares of INTERCEPT PHARMACEUTICALS, INC. equalling to $1,236,906.64.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -56.44K |
$19.00 | -$1,072,417.00 |
0
|
Nov 8
| |||
Form 4
| -1.35% | -771.00 |
$18.96 | -$14,618.16 | 56.44K |
Nov 1
| |||
Form 4
| -1.33% | -771.00 |
$10.50 | -$8,095.50 | 57.21K |
Aug 1
| |||
Form 4
| -1.31% | -771.00 |
$17.07 | -$13,160.97 | 57.98K |
May 1
| |||
Form 4
| -1.54% | -918.00 |
$18.76 | -$17,221.68 | 58.76K |
Feb 1
| |||
Form 4
| +25.70% | 12.2K |
—
|
—
| 59.67K |
Jan 27
| |||
Form 4
| -1.49% | -718.00 |
$12.37 | -$8,881.66 | 47.47K |
Dec 31
| |||
Form 4
| -1.57% | -771.00 |
$15.73 | -$12,127.83 | 48.19K |
Nov 1
| |||
Form 4
| -1.55% | -771.00 |
$12.21 | -$9,413.91 | 48.96K |
Aug 1
| |||
Form 4
| -1.53% | -771.00 |
$15.71 | -$12,112.41 | 49.73K |
May 1
| |||
Form 4
| -7.46% | -4.07K |
$16.91 | -$68,857.52 | 50.51K |
Feb 1
| |||
Form 4
| +23.26% | 10.3K |
—
|
—
| 54.58K |
Jan 27
| |||
Form 4
|
∞
| 44.28K |
—
|
—
| 44.28K |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||